A detailed history of Oarsman Capital, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Oarsman Capital, Inc. holds 21,130 shares of AZN stock, worth $1.41 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
21,130
Previous 17,988 17.47%
Holding current value
$1.41 Million
Previous $1.4 Million 17.4%
% of portfolio
0.31%
Previous 0.31%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$76.67 - $87.62 $240,897 - $275,302
3,142 Added 17.47%
21,130 $1.65 Million
Q2 2024

Aug 12, 2024

BUY
$66.81 - $80.83 $263,498 - $318,793
3,944 Added 28.08%
17,988 $1.4 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $87,333 - $99,554
-1,431 Reduced 9.25%
14,044 $951,000
Q4 2023

Feb 16, 2024

BUY
$61.89 - $69.28 $23,146 - $25,910
374 Added 2.48%
15,475 $1.04 Million
Q3 2023

Oct 27, 2023

BUY
$64.85 - $71.7 $3,501 - $3,871
54 Added 0.36%
15,101 $1.02 Million
Q2 2023

Aug 10, 2023

SELL
$69.91 - $75.81 $5,452 - $5,913
-78 Reduced 0.52%
15,047 $1.08 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $84,936 - $96,301
1,345 Added 9.76%
15,125 $1.05 Million
Q4 2022

Feb 09, 2023

SELL
$54.21 - $70.44 $182,145 - $236,678
-3,360 Reduced 19.6%
13,780 $934,000
Q3 2022

Nov 10, 2022

SELL
$53.02 - $135.75 $13,255 - $33,937
-250 Reduced 1.44%
17,140 $940,000
Q2 2022

Aug 10, 2022

SELL
$59.26 - $71.14 $22,518 - $27,033
-380 Reduced 2.14%
17,390 $1.15 Million
Q1 2022

May 11, 2022

BUY
$55.72 - $67.12 $34,825 - $41,950
625 Added 3.65%
17,770 $1.18 Million
Q4 2021

Feb 10, 2022

BUY
$54.02 - $63.83 $7,832 - $9,255
145 Added 0.85%
17,145 $999,000
Q3 2021

Nov 12, 2021

SELL
$55.56 - $60.79 $833 - $911
-15 Reduced 0.09%
17,000 $1.02 Million
Q2 2021

Aug 12, 2021

BUY
$48.42 - $60.18 $823,866 - $1.02 Million
17,015 New
17,015 $1.02 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Oarsman Capital, Inc. Portfolio

Follow Oarsman Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.